{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:42:47Z","timestamp":1792593767202,"version":"4.5.0"},"reference-count":12,"publisher":"MyJove Corporation","issue":"225","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68269","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:31Z","timestamp":1762560031000},"source":"Crossref","is-referenced-by-count":0,"title":["A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance"],"prefix":"10.3791","author":[{"given":"Chun-Long","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"1","key":"ref1","first-page":"12","type":"journal-article","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N., Jemal, A. Cancer statistics, 2024. CA Cancer J Clin. 74 (1), 12-49 (2024).","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","type":"journal-article","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: Screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","unstructured":"Cornford, P. et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: Screening, diagnosis, and local treatment with curative intent. Eur Urol. 86 (2), 148-163 (2024).","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2340\/sju.v59.40123","type":"journal-article","article-title":"Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study","volume":"59","author":"Maljkovic","year":"2024","unstructured":"Maljkovic, J. et al. Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study. Scand J Urol. 59, 200-206 (2024).","journal-title":"Scand J Urol"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.juro.2014.03.033","type":"journal-article","article-title":"Targeted focal therapy for the management of organ-confined prostate cancer","volume":"192","author":"Barqawi","year":"2014","unstructured":"Barqawi, A. B. et al. Targeted focal therapy for the management of organ-confined prostate cancer. J Urol. 192 (3), 749-753 (2014).","journal-title":"J Urol"},{"issue":"17","key":"ref5","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMcibr0905562","type":"journal-article","article-title":"The index lesion and the origin of prostate cancer","volume":"361","author":"Ahmed","year":"2009","unstructured":"Ahmed, H. U. The index lesion and the origin of prostate cancer. N Engl J Med. 361 (17), 1704-1706 (2009).","journal-title":"N Engl J Med"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.juro.2007.08.072","type":"journal-article","article-title":"Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities","volume":"178","author":"Eggener","year":"2007","unstructured":"Eggener, S. E. et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol. 178 (6), 2260-2267 (2007).","journal-title":"J Urol"},{"issue":"2","key":"ref7","first-page":"6672","type":"journal-article","article-title":"Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance","volume":"20","author":"Sommer","year":"2013","unstructured":"Sommer, G. et al. Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance. Can J Urol. 20 (2), 6672-6681 (2013).","journal-title":"Can J Urol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bju.12370","type":"journal-article","article-title":"Focal cryoablation: a treatment option for unilateral low-risk prostate cancer","volume":"113","author":"Durand","year":"2014","unstructured":"Durand, M. et al. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer. BJU Int. 113 (1), 56-64 (2014).","journal-title":"BJU Int"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1016\/j.clon.2021.07.016","type":"journal-article","article-title":"Multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: an updated systematic review","volume":"33","author":"Haider","year":"2021","unstructured":"Haider, M. A. et al. Multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: an updated systematic review. Clin Oncol (R Coll Radiol). 33 (12), e599-e612 (2021).","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"Suppl 2","key":"ref10","doi-asserted-by":"crossref","first-page":"67S","DOI":"10.2967\/jnumed.116.186767","type":"journal-article","article-title":"Prostate-specific membrane antigen ligands for imaging and therapy","volume":"58","author":"Eiber","year":"2017","unstructured":"Eiber, M. et al. Prostate-specific membrane antigen ligands for imaging and therapy. J Nucl Med. 58 (Suppl 2), 67S-76S (2017).","journal-title":"J Nucl Med"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2019.03.007","type":"journal-article","article-title":"Robot-assisted radical prostatectomy after focal therapy: oncological, functional outcomes and predictors of recurrence","volume":"76","author":"Marconi","year":"2019","unstructured":"Marconi, L. et al. Robot-assisted radical prostatectomy after focal therapy: oncological, functional outcomes and predictors of recurrence. Eur Urol. 76 (1), 27-30 (2019).","journal-title":"Eur Urol"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.euf.2021.10.005","type":"journal-article","article-title":"Outcomes of salvage robot-assisted radical prostatectomy after focal ablation for prostate cancer in comparison to primary robot-assisted radical prostatectomy: a matched analysis","volume":"8","author":"Bhat","year":"2022","unstructured":"Bhat, K. R. S. et al. Outcomes of salvage robot-assisted radical prostatectomy after focal ablation for prostate cancer in comparison to primary robot-assisted radical prostatectomy: a matched analysis. Eur Urol Focus. 8 (5), 1192-1197 (2022).","journal-title":"Eur Urol Focus"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68269\/a-new-technique-for-treating-low-risk-prostate-cancersuper-active","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:15:57Z","timestamp":1792592157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68269\/a-new-technique-for-treating-low-risk-prostate-cancersuper-active"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":12,"journal-issue":{"issue":"225","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68269","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]}}}